Brief: Century Therapeutics Shares Open 2.5% Below IPO Price In Nasdaq Debut
18/06/2021 17:18
June 18 (Reuters) -
* CENTURY THERAPEUTICS SHARES OPEN AT $19.50 IN NASDAQ DEBUT
VERSUS IPO PRICE OF $20.00/SHARE
Further company coverage: IPSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview